PIONEER WOUND HEALING & LYMPHOEDEMA CENTRES NO.2 LIMITED

Company Registration Number:
13760618 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

PIONEER WOUND HEALING & LYMPHOEDEMA CENTRES NO.2 LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

PIONEER WOUND HEALING & LYMPHOEDEMA CENTRES NO.2 LIMITED

Balance sheet

As at 31 December 2023


Notes

2023

13 months to 31 December 2022


£

£
Fixed assets
Investments: 3 604,812 604,812
Total fixed assets: 604,812 604,812
Current assets
Debtors:   322,228 323,068
Total current assets: 322,228 323,068
Creditors: amounts falling due within one year:   (325,690) (325,690)
Net current assets (liabilities): (3,462) (2,622)
Total assets less current liabilities: 601,350 602,190
Total net assets (liabilities): 601,350 602,190
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 601,349 602,189
Shareholders funds: 601,350 602,190

The notes form part of these financial statements

PIONEER WOUND HEALING & LYMPHOEDEMA CENTRES NO.2 LIMITED

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 12 June 2024
and signed on behalf of the board by:

Name: Mr R Widdowson
Status: Director

The notes form part of these financial statements

PIONEER WOUND HEALING & LYMPHOEDEMA CENTRES NO.2 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

PIONEER WOUND HEALING & LYMPHOEDEMA CENTRES NO.2 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

2023 13 months to 31 December 2022
Average number of employees during the period 0 0

PIONEER WOUND HEALING & LYMPHOEDEMA CENTRES NO.2 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Fixed investments

Investments Cost 31 December 2023 604,812